NCT06443944 2026-03-06
An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
CG Oncology, Inc.
Available
Clinical Trials
4 trialsNCT05494411 2025-02-28
Named Patient Program for Mitomycin for Pyelocalyceal Solution
UroGen Pharma Ltd.
Available
NCT04136808 2020-01-13
An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Urothelial Carcinoma
Astellas Pharma Inc
Approved for marketing
NCT02589717 2016-11-02
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Genentech, Inc.
Approved for marketing